Original Article

You have full text access to this OnlineOpen article

Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women

  1. Patricia A. Carney Ph.D.†,*,
  2. Beth G. Harwood M.Ed.,
  3. Julie E. Weiss M.S.,
  4. M. Scottie Eliassen M.S.,
  5. Martha E. Goodrich B.S.

Article first published online: 11 JUL 2002

DOI: 10.1002/cncr.10681

Issue

Cancer

Cancer

Volume 95, Issue 2, pages 219–227, 15 July 2002

Additional Information

How to Cite

Carney, P. A., Harwood, B. G., Weiss, J. E., Eliassen, M. S. and Goodrich, M. E. (2002), Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer, 95: 219–227. doi: 10.1002/cncr.10681

Author Information

  1. Department of Community & Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire

  1. †

    Fax: (603) 650-6333

*Dartmouth Medical School 1, Medical Center Dr., HB 7925, Lebanon, NH 03756

Publication History

  1. Issue published online: 11 JUL 2002
  2. Article first published online: 11 JUL 2002
  3. Manuscript Accepted: 15 FEB 2002
  4. Manuscript Revised: 13 FEB 2002
  5. Manuscript Received: 14 JAN 2002

Funded by

  • American Cancer Society. Grant Number: (CRTG-98-280-01-CCE)
  • U.S. Department of Defense. Grant Number: (DASD17-94-J-4109)
  • National Cancer Institute. Grant Number: (U01 CA86082-01)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (80K)

REFERENCES

  • 1
    Annual Report of the New Hampshire Department of Health and Human Services, Concord, NH. New Hampshire State Cancer Registry, 1993.
  • 2
    Chen VW, Wu XC. Cancer in North America, 1990–1994. Volume II: Mortality. Sacramento, CA: North American Association of Central Cancer Registries, 1998.
  • 3
    Tabar L, Vitak B, Chen HT, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001; 91: 1724–1731.
    Direct Link:
  • 4
    Breen N, Kessler L. Trends in cancer screening: United States, 1987 and 1992. Oncology. 1996; 10: 328–330.
  • 5
    Urban N, Taplin SH, Taylor VM, Peacock S, Anderson G, Conrad D. Community organization to promote breast cancer screening among women ages 50–75. Prev Med. 1995; 24: 477–484.
  • 6
    Meissner HI, Breen N, Coyne C, Legler JM, Green DT, Edwards BK. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol Biomarkers Prev. 1998; 7: 951–961.
  • 7
    Anonymous. Self-reported use of mammography among women aged ≥ 40 years, United States, 1989–1995. MMWR. 1997; 46: 937–941.
  • 8
    Dolan NC, Reifler DR, McGrae, McDermott, McGaghie WC. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med. 1995; 10: 299–306.
  • 9
    Zapka JG, Stoddard A, Maul L, Costanza ME. Interval adherence to mammography screening guidelines. Med Care. 1991; 2: 697–707.
  • 10
    Rimer BK, Trock B, Engstrom PF, Lerman, C, King E. Why do some women get regular mammograms. Am J Prev Med. 1991; 7: 69–74.
  • 11
    Mayer JA, Slymen DJ, Jones JA, et al. Mammography knowledge and intentions among insured women. Prev Med. 1992; 21: 8–17.
  • 12
    Lerman C, Rimer, B, Trock, B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990; 19: 279–290.
  • 13
    Chrvala C. Breast cancer risk status as a predictor for breast cancer screening behaviors. Prog Clin Biol Res. 1990; 339: 239–251.
  • 14
    Lerman C, Daly M, Sands C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 1993; 85: 1074–1080.
  • 15
    RiesLAG, MillerBA, HankeyBF, editors. SEER cancer statistics review, 1973–1991. Bethesda: National Cancer Institute, 1994.
  • 16
    Colditz GA, Wiett WC, Hunter DJ. Family history age and risk of breast cancer. JAMA. 1993; 270: 338–343.
  • 17
    London SJ, Connolly JL, Schnitt SJ. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992; 267: 941–944.
  • 18
    Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev. 1993; 15: 177–187.
  • 19
    Harris JR, Lippman ME, Veronesi U. Breast cancer. N Engl J Med. 1992; 327: 319–327.
  • 20
    Laya MB, Gallagher JC, Schreiman JA. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995; 196: 443–437.
  • 21
    Stomper PC, Van Voorhis BJ, Ravkinar VA. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology. 1990; 174: 487–490.
  • 22
    Leung W, Goldberg F, Zee B, Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery. 1997; 122: 669–674.
  • 23
    Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev. 1990; 12: 228–240.
  • 24
    Grady D, Rubin SM, Petitti DB. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med. 1992; 117: 1016–1037.
  • 25
    Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995; 87: 670–675.
  • 26
    McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000; 48: 1226–1233.
  • 27
    Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000; 38: 625–651.
  • 28
    Carney PA, Poplack SP, Wells WA, Littenberg B. Development and design of a population-based mammography registry: the New Hampshire Mammography Network. AJR Am J Roentgenol. 1996; 167: 367–372.
  • 29
    D'Orsi CJ, Bassett LW, Feig SA, et al. Breast imaging reporting and data system. 3rd ed. Reston, Va: American College of Radiology, 1998.
  • 30
    Black WC, Nease RF Jr., Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 1995; 87: 720–731.
  • 31
    Woloshin S, Schwartz LM, Byram S, Fishhoff B, Welch H. A new scale for assessing perceptions of chance: a validation study. Med Decis Making. 2000; 20: 298–307.
  • 32
    Speilberger CD, Gorsuch RL, Lushene RE. Manual for the State Trait Anxiety Inventory (Self©Evaluation Questionnaire). Palo Alto, Ca: Consulting Psychologists Press, 1970.
  • 33
    Champion V. Development of a benefits and barriers scale for mammography utilization. Cancer Nurs. 1995; 18: 53–59.
  • 34
    Schottenfield D, Kerner J. Final Report© Cancer Control Development Grant (National Cancer Institute grant- CA-16402). Bethesda: National Cancer Institute, 1984.
  • 35
    Kash KM, Holland JC, Osborne MP, Miller DG. Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr. 1995; 17: 73–79.
View Full Article (HTML) Get PDF (80K)